Although not approved specifically for PCOS, GLP-1 RA use in women with PCOS has been associated with improved blood glucose control and weight loss, as well as improvements in menstrual regularity and a decrease in ovarian cysts ( 4 , 6 8 )
[7] Two trials in the phase 3 TRIUMPH program reached primary completion in April 2026: TRIUMPH-1, a master protocol in adults with obesity or overweight, and TRIUMPH-3, in participants with severe obesity and established cardiovascular disease
Recommended use: Take two capsules daily with plenty of water ideally before training or, on rest days, before bedtime
As expected 31,32 , GLP-1-G 2 ( 1 ) was 2.5 times less potent than GLP-1, with still a 50% effective concentration (EC 50 ) of 0.24 nM
Our legal team is focused on cases where patients suffered severe and often life-altering injuries after using a name-brand GLP-1 medication